Maze Therapeutics (MAZE) is down -29.8%, or -$14.60 to $34.40.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MAZE:
- Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James
- Maze Therapeutics falls -33.2%
- Leerink remains bullish on Maze, says Vertex comparison ‘apples to oranges’
- Maze Therapeutics price target raised to $110 from $60 at H.C. Wainwright
- Maze Therapeutics reports Q4 EPS (65c), consensus (78c)